Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Shares of CureVac climbed after the European Patent Office confirmed the validity of a patent that has been the subject of a lawsuit filed by BioNTech. The stock rose 7% to $2.99 on Friday. Shares ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

Before joining Moderna, Cronin spent close to 20 years at Ogilvy, working within its global healthcare department in ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...

CoV-2, has affected millions of people worldwide. Despite the virus’ primary target being the respiratory system, it has ...

In the five years since the outbreak of the pandemic, Republicans and Christians have seen a complete shift in their ...

As vaccine sentiment fluctuates and political scrutiny increases, Yale researchers weigh in on scientific transparency, ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

European Patent Office largely dismisses opposition filed by BioNTech SE in April 2023 challenging validity of EP 3 708 668 B1 and maintains the patent in amended formA hearing on infringement of EP 3 ...

The shocking rise of aggressive cancers post-COVID-19 is prompting concerns from health experts about the long-term consequences of mRNA vaccines. One of the world's leading oncologists, Dr. Patrick ...